|
RDH14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.16430004421164E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66049999978024E-07 |
| Normal-vs-Stage2 |
6.19659999999689E-05 |
| Normal-vs-Stage3 |
1.96080041092728E-10 |
| Normal-vs-Stage4 |
1.68729996641304E-09 |
| Stage1-vs-Stage2 |
6.204600E-01 |
| Stage1-vs-Stage3 |
2.204200E-02 |
| Stage1-vs-Stage4 |
1.643530E-02 |
| Stage2-vs-Stage3 |
2.914000E-01 |
| Stage2-vs-Stage4 |
1.663020E-01 |
| Stage3-vs-Stage4 |
5.137400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.72739658319688E-11 |
| Normal-vs-AfricanAmerican |
3.005300E-04 |
| Normal-vs-Asian |
3.220000E-03 |
| Caucasian-vs-AfricanAmerican |
5.157800E-01 |
| Caucasian-vs-Asian |
2.334000E-02 |
| AfricanAmerican-vs-Asian |
3.913400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.29479998629046E-09 |
| Normal-vs-Female |
1.73619999488395E-08 |
| Male-vs-Female |
3.224800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.09180000490628E-08 |
| Normal-vs-Age(41-60Yrs) |
4.51159998249295E-09 |
| Normal-vs-Age(61-80Yrs) |
8.50829995346913E-09 |
| Normal-vs-Age(81-100Yrs) |
4.640600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.072600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.212800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.814200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.979800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.882200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.752600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.106400E-02 |
| Classical-VS-Follicular |
2.432800E-01 |
| Classical-VS-Other |
6.883600E-01 |
| Classical-VS-Normal |
9.59399999445054E-08 |
| Tall-VS-Follicular |
1.178170E-01 |
| Tall-VS-Other |
5.385000E-01 |
| Tall-VS-Normal |
2.46130005265854E-09 |
| Follicular-VS-Other |
9.626200E-01 |
| Follicular-VS-Normal |
2.93619999980343E-07 |
| Other-VS-Normal |
1.499610E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.97169996890767E-09 |
| Normal-vs-N1 |
2.75489999701506E-08 |
| N0-vs-N1 |
1.574410E-01 |
|
|
